| Breakdown | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.73M | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 2.73M | -41.68K | -55.28K | -199.00K | -136.00K |
| EBITDA | -2.46M | -5.36M | -4.26M | -2.99M | -1.32M |
| Net Income | -2.66M | -4.74M | -2.44M | -3.21M | 120.26K |
Balance Sheet | |||||
| Total Assets | 92.50M | 95.40M | 62.47M | 37.39M | 12.31M |
| Cash, Cash Equivalents and Short-Term Investments | 2.42M | 565.15K | 6.89M | 15.25M | 954.25K |
| Total Debt | 7.79M | 13.86M | 15.37M | 5.59M | 698.40K |
| Total Liabilities | 43.84M | 53.78M | 36.16M | 14.68M | 8.15M |
| Stockholders Equity | 48.67M | 41.63M | 26.31M | 22.71M | 4.16M |
Cash Flow | |||||
| Free Cash Flow | 1.91M | -15.85M | -22.31M | -9.42M | 4.53M |
| Operating Cash Flow | 8.10M | 11.50M | -4.31M | -3.74M | 5.89M |
| Investing Cash Flow | -6.24M | -16.98M | -18.04M | -5.69M | -1.54M |
| Financing Cash Flow | 6.24K | -854.18K | 13.99M | 23.72M | -3.43M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
54 Neutral | AU$70.68M | -2.13 | -19.61% | ― | ― | 42.65% | |
52 Neutral | AU$47.42M | 1.06 | -0.34% | ― | ― | -100.38% | |
52 Neutral | AU$108.26M | -8.22 | -15.05% | ― | ― | 76.36% | |
50 Neutral | AU$58.82M | 31.80 | 4.75% | ― | ― | ― | |
47 Neutral | AU$56.30M | -7.27 | -5.89% | ― | ― | 59.26% | |
34 Underperform | AU$77.16M | -3.77 | -440.50% | ― | ― | -61.06% |
Latrobe Magnesium Limited has achieved continuous production of about 20 tonnes of magnesium oxide at its Hazelwood North demonstration plant, using brown coal ash over a sustained two-week operating period. The company reports that the magnesium oxide meets required quality standards and has already been sold to a customer, marking a key validation of its proprietary process.
The stabilised plant operations, following rectification of a gas transport fan defect, have allowed Latrobe to optimise its spray roaster and demonstrate ongoing production of magnesium oxide and by-products such as char, iron oxide and agricultural lime. Management says this milestone substantially de-risks the project and positions the company to move toward magnesium metal production and eventual commercial operations, with by-product validation trials now planned for potential customers and the planned Stage 2 commercial plant.
The most recent analyst rating on (AU:LMG) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Latrobe Magnesium Limited stock, see the AU:LMG Stock Forecast page.
Latrobe Magnesium Limited has notified the market of the cessation of 3,000,000 listed options (LMGAE), which expired unexercised on 5 January 2026, having carried an exercise price of $0.10 and an original expiry date of 22 December 2025. The expiry of these options without conversion marginally reduces the company’s potential future share dilution and clarifies its capital structure for investors, but does not involve any immediate cash inflow or operational change for the business.
The most recent analyst rating on (AU:LMG) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Latrobe Magnesium Limited stock, see the AU:LMG Stock Forecast page.
Latrobe Magnesium has received a non-binding and conditional Letter of Support from Export Finance Australia, indicating potential participation in financing its planned 10,000 tonne-per-annum Stage 2 commercial magnesium plant in Victoria, alongside a previously announced non-binding Letter of Interest from the US Export-Import Bank for up to A$200 million in debt. The company plans to appoint Bechtel to complete a bankable feasibility study within nine months, is seeking A$200 million in debt and A$50 million in equity, and has already allocated 100% of the plant’s output under an offtake agreement for the US market, underscoring its role in diversifying Western supply of a critical mineral currently dominated by China and Russia and strengthening its strategic positioning in the US–Australia critical minerals partnership.
Latrobe Magnesium has received a $6.29 million research and development tax incentive from the Australian Taxation Office, which it has applied directly to reduce its debt to financier RnD Funding, cutting the outstanding balance on its R&D facility to about $2.6 million. The company expects to clear this remaining liability through the planned sale of two surplus property lots for a combined $2.8 million, while also flagging a dispute over a lease extension with RnD that remains under negotiation and has been disclosed as a contingent liability, developments that collectively improve its near‑term funding position as it advances commissioning of its magnesium demonstration plant and longer-term expansion plans.
Latrobe Magnesium Limited has provided an update on its ongoing mediation process with Mincore Pty Ltd, emphasizing its commitment to the process without commenting on the potential outcomes. This development is part of LMG’s broader strategy to advance its magnesium production capabilities, which includes the commissioning of a Demonstration Plant and plans for larger-scale operations in Australia and Malaysia. The company’s focus on recycling industrial waste and reducing CO2 emissions positions it as a leader in environmentally sustainable practices within the magnesium industry.
Latrobe Magnesium Limited has successfully addressed a mechanical defect in its Stage 1 Demonstration Plant in Hazelwood North, which temporarily halted operations. The issue was traced to a manufacturing defect in the Spray Roaster gas transport fan, and corrective measures have been implemented with the help of various technical stakeholders. The plant has now resumed operations, with improvements made to ensure long-term reliability and efficiency. The company is also exploring new materials for future projects to reduce maintenance complexity. These developments are expected to strengthen Latrobe Magnesium’s operational capabilities and support its market positioning as it aims for continuous MgO production and future sales.
Latrobe Magnesium Limited has announced the quotation of 3,491,979 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of December 5, 2025. This move is part of previously announced transactions and may enhance the company’s liquidity and market positioning, potentially benefiting stakeholders by increasing the company’s capital base and visibility in the market.
Latrobe Magnesium Limited has announced the application for the quotation of 2,000,000 ordinary fully paid securities on the Australian Securities Exchange (ASX). This move follows the approval of the Employee Acquisition Plan by security holders in the 2021 Annual General Meeting. The issuance of these securities is part of the company’s ongoing efforts to enhance its market presence and operational capabilities, potentially impacting its industry positioning and stakeholder interests.
Latrobe Magnesium Limited has announced a proposed issue of 3,491,979 ordinary fully paid securities, as part of a placement or other type of issue. This move is expected to enhance the company’s financial resources, potentially impacting its operational capabilities and market positioning by providing additional capital to support its strategic initiatives.